Unicycive Therapeutics, Inc.
UNCY
$6.93
-$0.19-2.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.38M | 19.38M | 18.21M | 15.53M | 12.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.52M | 31.56M | 30.46M | 30.90M | 32.12M |
| Operating Income | -29.52M | -31.56M | -30.46M | -30.90M | -32.12M |
| Income Before Tax | -26.56M | -33.41M | -31.50M | -15.20M | -36.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.56 | -33.41 | -31.50 | -15.20 | -36.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.56M | -33.41M | -31.50M | -15.20M | -36.73M |
| EBIT | -29.52M | -31.56M | -30.46M | -30.90M | -32.12M |
| EBITDA | -29.48M | -31.52M | -30.44M | -30.88M | -32.10M |
| EPS Basic | -1.50 | -2.85 | -2.98 | 1.48 | -6.34 |
| Normalized Basic EPS | -0.93 | -1.78 | -1.86 | 0.09 | -3.69 |
| EPS Diluted | -2.04 | -3.39 | -3.52 | -4.46 | -11.73 |
| Normalized Diluted EPS | -0.93 | -1.78 | -1.86 | -0.88 | -4.66 |
| Average Basic Shares Outstanding | 63.48M | 52.62M | 43.45M | 34.94M | 26.75M |
| Average Diluted Shares Outstanding | 64.18M | 53.32M | 44.15M | 41.26M | 32.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 0.00% | 0.00% | -7.21% | -2.98% |